Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions.
about
Utilizing the Wikidata system to improve the quality of medical content in Wikipedia in diverse languages: a pilot studyToward a complete dataset of drug-drug interaction information from publicly available sourcesPharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision MedicineData-driven prediction of adverse drug reactions induced by drug-drug interactions.Potential drug-drug interactions among elderly patients admitted to medical ward of Ayder Referral Hospital, Northern Ethiopia: a cross sectional study.Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support.Text mining for drug-drug interaction.Prevalence of drug interactions in elderly patients with multimorbidity in primary care.Detection of drug-drug interactions through data mining studies using clinical sources, scientific literature and social media.Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice.Using Nonexperts for Annotating Pharmacokinetic Drug-Drug Interaction Mentions in Product Labeling: A Feasibility Study.Patient Characteristics Associated with Adverse Drug Events in Hospital: An Overview of ReviewsIncidence of Potential Drug-Drug Interactions in a Limited and Stereotyped Prescription Setting - Comparison of Two Free Online Pharmacopoeias.VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients.Potential drug interactions in patients with a history of cancer.Recommendations to improve the usability of drug-drug interaction clinical decision support alerts.Potential Drug-Drug Interactions Among Critically Ill Pediatric Patients in a Tertiary Pulmonary Center.Phenobarbital Treatment at a Neonatal Age Results in Decreased Efficacy of Omeprazole in Adult Mice.Potential drug-drug interactions in paediatric outpatient prescriptions in Nigeria and implications for the future.How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping.A cross-sectional study on drug use in multiple system atrophy.Drug-drug interaction study of ACT-178882, a new renin inhibitor, and diltiazem in healthy subjects.The prevalence and preventability of potentially relevant drug-drug interactions in patients admitted for cardiovascular diseases: A cross-sectional study.Systemic anticancer therapy (SACT) for lung cancer and its potential for interactions with other medicines.Characterisation of non-warfarin-associated bleeding events reported to the Norwegian spontaneous reporting system.Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug-drug interactions: a PharmacoVigilance study in France.A dataset quantifying polypharmacy in the United States.Potential drug-drug interactions among hospitalized patients in a developing country.Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.Drug drug interaction extraction from the literature using a recursive neural network.Formalizing Evidence Type Definitions for Drug-Drug Interaction Studies to Improve Evidence Base Curation.Actual drug-drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study.Comparative analysis of three drug-drug interaction screening systems against probable clinically relevant drug-drug interactions: a prospective cohort study.Potential Drug-Drug Interactions with Antimicrobials in Hospitalized Patients: A Multicenter Point-Prevalence Study.Drug-Drug Interaction Assessment and Identification in the Primary Care SettingComparing Drug-Drug Interaction Severity Ratings between Bedside Clinicians and Proprietary DatabasesPotentially serious drug interactions resulting from the pre-travel health encounter
P2860
Q21503276-3FB306BA-3318-4733-9E42-F65DE55FC0EEQ26896954-5C9009FA-EF8B-4903-B1D7-AEED66077474Q27692687-DD244518-145C-4289-A5A9-908DB2194ECFQ33781632-08A59D74-3D2B-40A7-A820-85A3C18FA35CQ36120277-1B898E28-159B-4E1B-9887-2ED945AB4BAFQ36219247-23A22A16-9762-4AC4-AC11-5D2AD3E266DCQ36259408-CFC9FC42-11EB-4EFE-9D5F-2CB0EC820B08Q36290903-E28E928D-EF24-43CA-BC95-CA867461C7B0Q36320218-0BF62552-B937-4FA3-A073-6275B5D1C299Q36410106-A6A2A981-B96F-4F96-8BE9-DE51DA4F7976Q36835297-815D371D-366B-4434-AE84-107861EB1220Q37225741-7D92B887-8D23-448C-BE9C-8B6BBDEC8EA2Q37527674-FFF2BC07-E88A-41C9-8454-C760CC35AF08Q37552063-14009056-1FB6-4A33-933C-52817BE7CAC3Q37719619-4C1D000F-969F-43D4-905C-737E3F3AEBF0Q38398699-40E4F6EA-6CAC-405F-8CCB-93F162DBD376Q38611632-B8DD5FE0-6DD5-4A5B-A5AD-C79AEE28FF8DQ38773723-083A7411-B1E7-40C1-90D7-7020FBEB1704Q38824529-E36ED1D3-E274-40F4-92E0-E3D14E2342B0Q39198151-9D6DF728-1178-44EE-ADAC-44F701695777Q39209254-74B112D2-2CC9-4713-B358-FB1C3A1E813FQ39472689-75CF38CC-F135-409C-8869-F952670236D6Q40067944-4171D361-CFFE-40D1-9B7F-404C0FD336C9Q41683801-F057874F-7A83-401A-927C-57A0B853964CQ45821018-8ECE7D86-98E0-42A5-A857-CCEB515FED4AQ45898539-F7B70CB7-75FD-4B20-BF25-C524109B216EQ45983542-46F2A9E0-8536-4E35-B896-BA7D1D25BDC5Q47129567-E488E086-AA65-4D68-AEE8-E9A8C0514BDCQ47643184-0D8C1EBE-D27C-48CD-8C8F-1E3203AD32EBQ48158949-056AE0BE-0092-4F20-A7E2-F6B0727EBDEDQ49278505-FA1932E7-1D97-41F2-90FE-76B6B416EE16Q50849068-7823571F-05C1-416C-B9D0-04703C05555AQ54261327-D48DD581-6C17-495F-B9C9-BF992CE81284Q55646748-763C046D-89D7-49BA-B3EE-FD39640C5F12Q57787835-4407431C-8D2B-412B-8F95-D69F40C11F16Q58994804-44DE0AC9-8DF4-42A3-9381-D429BCE3DC1BQ59125343-296901E6-DF31-41A2-A7D3-E5F7D80C68DE
P2860
Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epidemiology and characteristi ...... sed by drug-drug interactions.
@en
Epidemiology and characteristi ...... sed by drug-drug interactions.
@nl
type
label
Epidemiology and characteristi ...... sed by drug-drug interactions.
@en
Epidemiology and characteristi ...... sed by drug-drug interactions.
@nl
prefLabel
Epidemiology and characteristi ...... sed by drug-drug interactions.
@en
Epidemiology and characteristi ...... sed by drug-drug interactions.
@nl
P2860
P1476
Epidemiology and characteristi ...... used by drug-drug interactions
@en
P2093
Roberto Leone
Ugo Moretti
P2860
P356
10.1517/14740338.2012.631910
P407
P50
P577
2011-10-25T00:00:00Z